Success Metrics

Clinical Success Rate
100.0%

Based on 1 completed trials

Completion Rate
100%(1/1)
Active Trials
2(20%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_4
6
60%
Ph phase_3
2
20%
Ph phase_2
2
20%

Phase Distribution

0

Early Stage

2

Mid Stage

8

Late Stage

Phase Distribution10 total trials
Phase 2Efficacy & side effects
2(20.0%)
Phase 3Large-scale testing
2(20.0%)
Phase 4Post-market surveillance
6(60.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

1 of 1 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

2

trials recruiting

Total Trials

10

all time

Status Distribution
Active(2)
Completed(1)
Other(7)

Detailed Status

unknown7
Active, not recruiting2
Completed1

Development Timeline

Analytics

Development Status

Total Trials
10
Active
2
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 22 (20.0%)
Phase 32 (20.0%)
Phase 46 (60.0%)

Trials by Status

completed110%
active_not_recruiting220%
unknown770%

Recent Activity

2 active trials
Showing 5 of 10
active_not_recruitingphase_2

A Study Extension Period of PEG-somatropin (Pegylated-somatropin) in the Treatment of Children With Idiopathic Short Stature

NCT03255694
active_not_recruitingphase_2

Clinical Study of Pegylated Somatropin (PEG Somatropin) to Treat SGA Children With Short Stature

NCT02375620
unknownphase_3

A Study to Investigate the Safety and Efficacy of Once-weekly PEG-somatropin (GenSci004) in Children With Growth Hormone Deficiency

NCT06024967
unknownphase_4

Extension Study of Pegylated Somatropin to Treat Growth Retardation Caused by Endogenous Growth Hormone Deficiency in Children

NCT03290235
unknownphase_4

Pegylated Somatropin (PEG Somatropin) in the Treatment of Children With Growth Hormone Deficiency

NCT03249480
View all 10 trials

Clinical Trials (10)

Showing 10 of 10 trials
NCT03255694Phase 2

A Study Extension Period of PEG-somatropin (Pegylated-somatropin) in the Treatment of Children With Idiopathic Short Stature

Active Not Recruiting
NCT02375620Phase 2

Clinical Study of Pegylated Somatropin (PEG Somatropin) to Treat SGA Children With Short Stature

Active Not Recruiting
NCT06024967Phase 3

A Study to Investigate the Safety and Efficacy of Once-weekly PEG-somatropin (GenSci004) in Children With Growth Hormone Deficiency

Unknown
NCT03290235Phase 4

Extension Study of Pegylated Somatropin to Treat Growth Retardation Caused by Endogenous Growth Hormone Deficiency in Children

Unknown
NCT03249480Phase 4

Pegylated Somatropin (PEG Somatropin) in the Treatment of Children With Growth Hormone Deficiency

Unknown
NCT01495468Phase 3

Phase III Clinical Study of Pegylated Somatropin (PEG Somatropin) to Treat Growth Hormone Deficiency Children

Completed
NCT02976675Phase 4

Pegylated Somatropin (PEG Somatropin) in the Treatment of Children With Growth Hormone Deficiency

Unknown
NCT02380235Phase 4

Phase IV Clinical Study of Pegylated Somatropin (PEG Somatropin) to Treat Growth Hormone Deficiency Children (Clinical Trial I)

Unknown
NCT02908958Phase 4

Clinical Study of Pegylated Somatropin to Treat Children Growth Hormone Deficiency

Unknown
NCT02314676Phase 4

Phase IV Clinical Study of Pegylated Somatropin (PEG Somatropin) to Treat Growth Hormone Deficiency Children

Unknown

All 10 trials loaded

Drug Details

Intervention Type
BIOLOGICAL
Total Trials
10